Novozymes raises 2026 outlook after H1 sales growth
Novozymes said H1 organic sales grew 8% and adjusted EPS excluding PPA amortization rose 9% to €1.09, while it lifted full-year organic sales growth guidance to 7%-8%.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.